Ishita Drugs & Industries Ltd.

80.75 +0.84 ▲1.1%

21 February 2024, 04:01:00 PM
Volume: 6,130

Company Profile

Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.ishitadrugs.com
Market Cap 23.97 Cr.
Enterprise Value(EV) 21.20 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 2.16 Trailing Twelve Months Ending 2023-12
Price-Earning Ratio (PE) 37.10 Trailing Twelve Months Ending 2023-12
Industry PE 41.82 Trailing Twelve Months Ending 2023-12
Book Value / Share 32.23 Trailing Twelve Months Ending 2023-12
Price to Book Value 2.49 Calculated using Price: 80.15
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 0.30 Cr. 2,990,300 Shares
FaceValue 10
About Ishita Drugs & Industries Ltd.
Ishita drugs & industries limited (IDIL), an Ishita Group company was incorporated in 1992, the company is listed on the local stock exchanges in India and has earned a reputation as a 'high quality manufacturer' in a very short time.

Ishita Drugs & Industries Ltd. Delivery

Delivered Qty
Traded Qty

Ishita Drugs & Industries Ltd. Performance

1 Day
+1.05%
1 Week
+11.24%
1 Month
+9.45%
3 Month
+17.13%
6 Month
+21.79%
1 Year
+63.63%
2 Year
+87.14%
5 Year
+390.88%
10 Year
+216.05%

Ishita Drugs & Industries Ltd. Fundamental Ratios

9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 4.12 2.47 3.19 4.17 5.64 8.18 11.25 9.82 6.5
Return on Capital Employed (%) 5.98 4.02 4.79 7.26 8.17 10.79 14.39 13 8.9
Return on Assets (%) 3.26 1.81 2.37 3.46 4.54 6.12 8.82 7.85 5.1

Ishita Drugs & Industries Ltd. Balance Sheet

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 5 6 6 6 6 7 8 9 9 10
Non Curr. Liab. 0 0 0 0 0 0 0 0 0 0
Curr. Liab. 1 3 1 1 2 3 1 3 2 3
Minority Int.
Equity & Liab. 7 8 7 7 8 10 9 11 11 13
Non Curr. Assets 1 1 1 1 2 1 1 1 1 1
Curr. Assets 6 7 6 6 7 8 8 10 10 12
Misc. Exp. not W/O
Total Assets 7 8 7 7 8 10 9 11 11 13

Ishita Drugs & Industries Ltd. Profit and Loss

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-12 Rs. Cr. TTM
Net Sales 7 7 6 7 9 15 14 14 12 13
Other Income 0 0 0 0 0 0 0 0 0 0
Total Income 7 7 6 7 9 15 14 14 12 14
Total Expenditure -7 -6 -6 -6 -9 -14 -13 -13 -11 -12
PBIDT 0 0 0 1 1 1 1 1 1 1
Interest 0 0 0 0 0 0 0 0 0 0
Depreciation 0 0 0 0 0 0 0 0 0 0
Taxation 0 0 0 0 0 0 0 0 0 0
Exceptional Items
PAT 0 0 0 0 0 1 1 1 1 1
Adjusted EPS 1 0 1 1 1 2 3 3 2 2

Ishita Drugs & Industries Ltd. Cash Flow

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 1 0 0 1 1 1 1 -1 3 -3
Cash Fr. Inv. 0 0 0 -1 -1 -1 -1 2 -1 1
Cash Fr. Finan. 0 0 1 -1 0 0 0 0 1
Net Change 0 0 1 -1 0 0 0 2 2 -1
Cash & Cash Eqvt 1 1 2 1 1 1 1 3 5 3

Ishita Drugs & Industries Ltd. Shareholding Pattern

9 Qtrs 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%)
Promoter 48.37 49.31 49.32 49.32 49.32 49.38 49.38 49.38 49.38
Public 51.63 50.69 50.68 50.68 50.68 50.62 50.62 50.62 50.62
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Ishita Drugs & Industries Ltd. Announcements

Tue, 13 Feb 2024
Board Meeting Outcome for Outcome Of Board Meeting Held On 13Th February 2024
Board of Directors of Ishita Drugs and Industries Limited at its meeting held today i.e.13th February 2024 have 1. Approved the Unaudited Financial Results with Limited Review Report issued by the Statutory Auditors of the Company for the quarter ended 31st December 2023.
Tue, 13 Feb 2024
Outcome Of Board Meeting Held On 13Th February 2024
Approval of Unaudited Financial Results with Limited Review Report issued by Statutory Auditor of the Company for the quarter ended 31st December 2023.
Fri, 02 Feb 2024
Board Meeting Intimation for Intimation Of Board Meeting Pursuant To Regulation 29 And Regulation 33 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 For The Quarter Ended 31St December 2023.
ISHITA DRUGS & INDUSTRIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2024 inter alia to consider and approve the following business:1. To consider approve and take on record the Unaudited Financial Results of the Company for the quarter ended 31st December 2023.2. Any other matter with permission of the Chair.

Ishita Drugs & Industries Ltd. Technical Scans

Wed, 21 Feb 2024
Opening at High Opening at High
High Increase in 1 Month High Increase in 1 Month
High Increase in 3 Months High Increase in 3 Months
High Increase in 6 Months High Increase in 6 Months
High Increase in 1 Year High Increase in 1 Year

Ishita Drugs & Industries Ltd. Related Stocks

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 370,313.36 1,543.40 +0.3%
Cipla Ltd. 116,866.14 1,447.30 -0.3%
Dr. Reddy's Laboratories Ltd. 105,898.11 6,349.15 -0.4%
Apollo Hospitals Enterprise Ltd. 97,179.74 6,760.15 +0.0%
Divi's Laboratories Ltd. 96,854.88 3,649.10 -1.7%
Zydus Lifesciences Ltd. 90,440.44 893.80 -0.2%
Torrent Pharmaceuticals Ltd. 88,043.20 2,603.00 -1.6%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 41.58 1,543.40 +0.3%
Cipla Ltd. Consolidated 2023-12 31.52 1,447.30 -0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 20.26 6,349.15 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 123.12 6,760.15 +0.0%
Divi's Laboratories Ltd. Consolidated 2023-12 70.03 3,649.10 -1.7%
Zydus Lifesciences Ltd. Consolidated 2023-12 30.41 893.80 -0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 58.93 2,603.00 -1.6%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 5.94 1,543.40 +0.3%
Cipla Ltd. Consolidated 2023-12 4.51 1,447.30 -0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 3.94 6,349.15 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 14.39 6,760.15 +0.0%
Divi's Laboratories Ltd. Consolidated 2023-12 7.43 3,649.10 -1.7%
Zydus Lifesciences Ltd. Consolidated 2023-12 4.65 893.80 -0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 12.31 2,603.00 -1.6%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,543.40 +0.3%
Cipla Ltd. Consolidated 2023-03 0.02 1,447.30 -0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 6,349.15 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 6,760.15 +0.0%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,649.10 -1.7%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 893.80 -0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,603.00 -1.6%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,543.40 +0.3%
Cipla Ltd. Consolidated 2023-03 12.85 1,447.30 -0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,349.15 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,760.15 +0.0%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,649.10 -1.7%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 893.80 -0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,603.00 -1.6%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,543.40 +0.3%
Cipla Ltd. Consolidated 2023-03 12.85 1,447.30 -0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,349.15 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,760.15 +0.0%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,649.10 -1.7%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 893.80 -0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,603.00 -1.6%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,543.40 +0.3%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,447.30 -0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 6,349.15 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 6,760.15 +0.0%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,649.10 -1.7%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 893.80 -0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,603.00 -1.6%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,543.40 +0.3%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,447.30 -0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 6,349.15 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 6,760.15 +0.0%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,649.10 -1.7%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 893.80 -0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,603.00 -1.6%

Ishita Drugs & Industries Ltd. FAQ's

What is Ishita Drugs & Inds. share price?

Can I buy Ishita Drugs & Inds. shares now?

What is the Market Cap of Ishita Drugs & Inds.?

What are the key metrics to analyse Ishita Drugs & Inds.?

What is the 52 Week High and Low of Ishita Drugs & Inds.?

What is the trend of Ishita Drugs & Inds. share price?